The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-11 of 11 articles
Heparin pretreatment in STEMI: is earlier always better?
October 21, 2022 | 10.4244/EIJ-E-22-00035
Antiplatelet therapy after percutaneous coronary intervention
April 1, 2022 | 10.4244/EIJ-D-21-00904
Angiographic predictors of outcome in myocardial infarction patients presenting with cardiogenic shock: a CULPRIT-SHOCK angiographic substudy
Overtchouk P,
Barthélémy O,
Hauguel-Moreau M,
Guedeney P,
Rouanet S,
Zeitouni M,
Silvain J,
Collet J,
Vicaut E,
Zeymer U,
Desch S,
Thiele H,
Montalescot G
February 5, 2021 | 10.4244/EIJ-D-20-00139
Impact of age on the effect of pre-hospital P2Y12 receptor inhibition in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: the ATLANTIC-Elderly analysis
Collet J,
Kerneis M,
Lattuca B,
Yan Y,
Cayla G,
Silvain J,
Lapostolle F,
Ecollan P,
Diallo A,
Vicaut E,
Hamm C,
van 't Hof AW,
Montalescot G
September 20, 2018 | 10.4244/EIJ-D-18-00182
The efficacy of early versus delayed P2Y12 inhibition in percutaneous coronary intervention for ST-elevation myocardial infarction: a systematic review and meta-analysis
Bellemain-Appaix A,
Begue C,
Bhatt D,
Ducci K,
Harrington R,
Roe M,
Wiviott SD,
Cucherat M,
Silvain J,
Collet J,
Bernasconi F,
Montalescot G
May 20, 2018 | 10.4244/EIJ-D-17-00852
Outcome after revascularisation of acute myocardial infarction with cardiogenic shock on extracorporeal life support
Overtchouk P,
Pascal J,
Lebreton G,
Hulot J-S,
Luyt C-E,
Combes A,
Kerneis M,
Silvain J,
Barthelemy O,
Leprince P,
Brechot N,
Montalescot G,
Collet J
April 6, 2018 | 10.4244/EIJ-D-17-01014
Intravenous enoxaparin anticoagulation in percutaneous left atrial cardiac procedures
Guedeney P,
Hammoudi N,
Duthoit G,
Yan Y,
Silvain J,
Pousset F,
Isnard R,
Redheuil A,
Kerneis M,
Collet J,
Montalescot G
November 20, 2017 | 10.4244/EIJ-D-17-00518
Antithrombotic therapy in TAVI patients: changing concepts
September 17, 2015 | 10.4244/EIJV11SWA28
Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement
Capodanno D,
Lip G,
Windecker S,
Huber K,
Kirchhof P,
Boriani G,
Lane D,
Gilard M,
Collet J,
Valgimigli M,
Byrne RA
January 22, 2015 | 10.4244/EIJV10I9A174
2014 ESC/EACTS Guidelines on myocardial revascularization
Windecker S,
Kolh P,
Alfonso F,
Collet J,
Cremer J,
Falk V,
Filippatos G,
Hamm C,
Head S,
Jüni P,
Kappetein A,
Kastrati A,
Knuuti J,
Landmesser U,
Laufer G,
Neumann F,
Richter D,
Schauerte P,
Uva M,
Stefanini G,
Taggart D,
Torracca L,
Valgimigli M,
Wijns W,
Witkowski A
January 22, 2015 | 10.4244/EIJY14M09_01
Antithrombotic and antiplatelet therapy in TAVI patients: a fallow field?
September 15, 2013 | 10.4244/EIJV9SSA9
Latest news
NEW ISSUE
The Bifurcation ARC consensus; impact of P2Y12 de-escalation in HBR; 5-year outcomes of the TARGET trial and more...
December 4, 2023
STATE-OF-THE-ART
Free access collection all year long
December 4, 2023
AHEAD OF PRINT
Poor improvement of post-PCI iFR in LAD
FREE ARTICLE - Mitsuaki Matsumura et al
November 30, 2023
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
PCR London Valves 2023
November 16, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023